Cited by 145Natural Antidiabetic Agents StudiesDiabetes Treatment and ManagementMedicinal Plant Research

Phytotherapy in diabetes: Review on potential mechanistic perspectives

Open access
El-Abhar, Hanan S, Schaalan, Mona F·2014·World Journal of Diabetes

Abstract

Diabetes mellitus (DM) is a widely spread epidemic disease that results from the absence of insulin, decreased secretion and/or impaired function. Since DM is a multi-factorial disease, the available pharmaceuticals, despite their sensible treatment, target mostly one pathway to control hyperglycemia and encounter several side effects. Therefore, new therapeutic paradigms aim to hit several pathways using only one agent. Traditionally, antidiabetic plants and/or their active constituents may fulfill this need. More than 200 species of plants possess antidiabetic properties which were evaluated mostly by screening tests without digging far for the exact mode of action. Searching among the different literature resources and various database and in view of the above aspects, the present article provides a comprehensive review on the available antidiabetic plants that have been approved by pharmacological and clinical evaluations, and which their mechanism(s) of action is assured. These plants are categorized according to their proved mode of action and are classified into those that act by inhibiting glucose absorption from intestine, increasing insulin secretion from the pancreas, inhibiting glucose production from hepatocytes, or enhancing glucose uptake by adipose and muscle tissues. The current review also highlights those that mimic in their action the new peptide analogs, such as exenatide, liraglutide and dipeptidylpeptidase-4 inhibitors that increase glucagon-like peptide-1 serum concentration and slow down the gastric emptying.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4239/wjd.v5.i2.176

Cites

206 of 206 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Extracts of various medicinal plants act at different levels by inhibiting glucose absorption from the intestine, increasing insulin secretion from the pancreas, increasing glucose uptake by adipose and muscle cells, and inhibiting glucose production from hepatocytes.

    “Extracts of various medicinal plants act at different levels by inhibiting the glucose absorption from intestine, increasing the insulin secretion from pancreas, increasing the uptake of glucose by adipose and muscle cells, inhibiting the glucose production from hepatocytes [57] .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

38 of the 244 references couldn’t be matched to a known paper.

Research works printed but not linked: 23

  1. López-Candales A. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J Med 2001; 32: 283-300 [PMID: 11958275]
  2. Omidbeygi R. Usage and Production of Medical Plant, vol. 2. Iran: Tarahan Nashre Press, 1997: 210-216
  3. Zargari A. Medicinal Plant, vol. 4. Iran: Tehran University Press, 1997: 59-64
  4. Sharma RD, Sarkar A, Hazra DK. Hypolipidemic effect of fenugreek seeds: a chronic study in non-insulin dependent diabetic patients. Phytother Res 1996; 10: 332-334 [DOI: 10.10 02/(SICI)1099-1573(199606)10: 4<332: : AID-PTR827>3.3.CO; 2-A]
  5. Vyas S, Agrawal RP, Solanki P, Trivedi P. Analgesic and anti-inflammatory activities of Trigonella foenum-graecum (seed) extract. Acta Pol Pharm 2008; 65: 473-476 [PMID: 19051589]
  6. Puri D. Therapeutic potentials of fenugreek. Indian J Physiol Pharmacol 1998; 42: 423-424 [PMID: 9741661]
  7. Mukherjee R, Jow L, Croston GE, Paterniti JR. Identification, characterization, and tissue distribution of human peroxi- some proliferator-activated receptor (PPAR) isoforms PPAR- gamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 1997; 272: 8071-8076 [PMID: 9065481]
  8. Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. Screening of herbal extracts for activa- tion of the human peroxisome proliferator-activated recep- tor. Pharmazie 2006; 61: 952-956 [PMID: 17152989] 107
  9. Karbowska J, Kochan Z. Role of adiponectin in the regula- tion of carbohydrate and lipid metabolism. J Physiol Pharma- col 2006; 57 Suppl 6: 103-113 [PMID: 17228091] 120
  10. Welihinda J, Arvidson G, Gylfe E, Hellman B, Karlsson E. The insulin-releasing activity of the tropical plant momordi- ca charantia. Acta Biol Med Ger 1982; 41: 1229-1240 [PMID: 6765165] 135
  11. Mathew PT, Augusti KT. Studies on the effect of allicin (diallyl disulphide-oxide) on alloxan diabetes. I. Hypogly- caemic action and enhancement of serum insulin effect and glycogen synthesis. Indian J Biochem Biophys 1973; 10: 209-212 [PMID: 4792931] 141
  12. Augusti KT. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol 1996; 34: 634-640 [PMID: 8979497] 142
  13. Eno AE, Ofem OE, Nku CO, Ani EJ, Itam EH. Stimulation of insulin secretion by Viscum album (mistletoe) leaf extract in streptozotocin-induced diabetic rats. Afr J Med Med Sci 2008; 37: 141-147 [PMID: 18939397] 148
  14. Scheen AJ. Glucagon-like peptide-1 (GLP-1), new target for the treatment of type 2 diabetes. Rev Med Liege 2007; 62: 217-221 [PMID: 17566392] 162
  15. Scheen AJ, Radermecker RP, Philips JC, Paquot N. Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes. Rev Med Suisse 2007; 3: 1884, 1886-1888 [PMID: 17896662] 163
  16. Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plas- ma glucose-lowering effect of tramadol in streptozotocin- induced diabetic rats. Diabetes 2001; 50: 2815-2821 [PMID: 11723065] 178
  17. Taguchi T, Brownlee M In: Pickkup JC, Williams G. (Eds). The biochemical mechanisms of diabetic tissue damage. Text Book of Diabetes. Oxford: Blackwell Science, 2003: 1-47 196
  18. Resmi CR, Venukumar MR, Latha MS. Antioxidant activity of Albizzia lebbeck (Linn.) Benth. in alloxan diabetic rats. Indian J Physiol Pharmacol 2006; 50: 297-302 [PMID: 17193903] 209
  19. Wu FH, Liang JY, Yu P, Cai SF. Studies on the hypoglycemia and lipids regulating effects of Plantago depressa var. mon- tata. Zhongguo Zhongyao Zazhi 2005; 30: 1179-1183 [PMID: 16201696] 216
  20. Soon YY, Tan BK. Evaluation of the hypoglycemic and anti- oxidant activities of Morinda officinalis in streptozotocin-in- duced diabetic rats. Singapore Med J 2002; 43: 077-085 [PMID: 11993894] 217
  21. Xie ZC, Qian ZK, Liu ZW. Effect of ginseng on antiperoxi- date injury in myocardium and erythrocytes in streptozocin- induced diabetic rats. Zhongguo Zhongxiyi Jiehe Zazhi 1993; 13: 289-290, 262 [PMID: 8219682] 221
  22. Raphael KR, Sabu MC, Kuttan R. Hypoglycemic effect of methanol extract of Phyllanthus amarus Schum & amp; Thonn on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential. Indian J Exp Biol 2002; 40: 905-909 [PMID: 12597020] 223
  23. Feng CG, Zhang LX, Liu X. [Progress in research of aldose reductase inhibitors in traditional medicinal herbs]. Zhong- guo Zhongyao Zazhi 2005; 30: 1496-1500 [PMID: 16335816] 225

Cited by

Sorted by citations

Authors
El-Abhar, H. S., & Schaalan, M. F.
Affiliations
Cairo University (EG)
Venue
World Journal of Diabetes
Published
2014
Volume
5
Issue
2
Pages
176
ISSN
1948-9358 (ISSN-L)
OpenAlex
W2115594023
Cited by
145
References
244
Citations by year
2026: 5 · 2025: 7 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 17 · 2020: 19 · 2019: 12 · 2018: 12 · 2017: 14 · 2016: 14 · 2015: 10 · 2014: 3
FWCI
2.18
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Diabetes (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
Keywords
herbal medicine, diabetes mellitus, antidiabetic plants, plant extracts, mechanism of action, glucose absorption inhibition, insulin secretion, hepatic glucose production, glucose uptake, exenatide, liraglutide, glucagon-like peptide-1, gastric emptying, hyperglycemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review